Skip to main content

Find Clinical Trials

Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,067 public trials 1,185 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Not yet recruiting

Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy

NCT06523049

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: West China Hospital Chengdu, Sichuan, China

View Trial Details

Not yet recruiting

Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations

NCT06519110

Conditions: Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +30 more
Locations: Not specified

View Trial Details

Not yet recruiting

Donafenib Combine With Sintilimab and HAIC in Neoadjuvant of Resectable Hepatocellular Carcinoma

NCT06512467

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Phase 2 Study: OBI-833/OBI-821 Maintenance for Globo H+ Advanced Biliary Tract Cancer After Gemcitabine/Cisplatin

NCT06490198

Conditions: Adenocarcinoma, Carcinoma, Chemotherapy Effect, +5 more
Locations: Chang Gung Memorial Hospital Linkou Branch Taoyuan, Taiwan

Chang-Gung Memorial Hospital, Linkou Branch Taoyuan, Taiwan

View Trial Details

Not yet recruiting

Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain Metastases

NCT06483672

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of Lung Metastatic to Brain, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

HAIC Combined With TQB2450 and Anlotinib in Second-line Treatment of Advanced Hepatocellular Carcinoma

NCT06475287

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

A Study of AK112 Monotherapy in Advanced/Metastatic Renal Cell Carcinoma

NCT06472895

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

Identification and Characterization of Circulating Tumor Cells Before and After Treatment (Surgery and Radiotherapy) in a Cohort of Patients Treated for Resectable Stage I-III Merkel Cell Carcinoma

NCT06448611

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +19 more
Locations: Not specified

View Trial Details

Not yet recruiting

Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma

NCT06449846

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +16 more
Locations: Shunde Hospital of Southern Medical University Foshan, Guangdong, China

The Sixth Affiliated Hospital of South China University of Technology Foshan, Guangdong, China

Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China

Sun Yat-sen University Cancer Center Guanzhou, Guangdong, China

View Trial Details

Not yet recruiting

Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion

NCT06089369

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details